A Comparison of Seroquel vs. Risperidone in Schizophrenia
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00034905
First received: May 2, 2002
Last updated: January 3, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.
| Condition | Intervention | Phase |
|---|---|---|
|
Schizophrenia |
Drug: quetiapine fumarate vs risperidone |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria
- Male / Female, 18-65 years old
- Schizophrenia (as per DSM IV)
Exclusion Criteria
- Concurrent use of psychotropic medication
- Does not fulfill moderately ill on CGI
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034905
Hide Study Locations
Hide Study LocationsLocations
| United States, Alabama | |
| Birmingham, Alabama, United States | |
| United States, Arizona | |
| Phoenix, Arizona, United States | |
| United States, California | |
| Anaheim, California, United States | |
| Cerritos, California, United States | |
| Chula Vista, California, United States | |
| Glendale, California, United States | |
| Hawthorne, California, United States | |
| Long Beach, California, United States | |
| San Diego, California, United States | |
| Santa Ana, California, United States | |
| Torrance, California, United States | |
| United States, Connecticut | |
| Farmington, Connecticut, United States | |
| New Haven, Connecticut, United States | |
| United States, District of Columbia | |
| Washington, District of Columbia, United States | |
| United States, Florida | |
| Miami, Florida, United States | |
| Miami Beach, Florida, United States | |
| North Miami, Florida, United States | |
| Winter Park, Florida, United States | |
| United States, Georgia | |
| Atlanta, Georgia, United States | |
| United States, Illinois | |
| Hoffman Estates, Illinois, United States | |
| United States, Kansas | |
| Prairie Village, Kansas, United States | |
| Wichita, Kansas, United States | |
| United States, Louisiana | |
| New Orleans, Louisiana, United States | |
| Shreveport, Louisiana, United States | |
| United States, Maryland | |
| Baltimore, Maryland, United States | |
| United States, Massachusetts | |
| Boston, Massachusetts, United States | |
| Worcester, Massachusetts, United States | |
| United States, Michigan | |
| Ann Arbor, Michigan, United States | |
| New Baltimore, Michigan, United States | |
| United States, Missouri | |
| Kansas City, Missouri, United States | |
| St. Louis, Missouri, United States | |
| United States, Nevada | |
| Reno, Nevada, United States | |
| United States, New Jersey | |
| Clementon, New Jersey, United States | |
| Lyons, New Jersey, United States | |
| Summit, New Jersey, United States | |
| United States, New Mexico | |
| Albuquerque, New Mexico, United States | |
| United States, New York | |
| Bronx, New York, United States | |
| Holliswood, New York, United States | |
| Montrose, New York, United States | |
| New York, New York, United States | |
| Oceanside, New York, United States | |
| White Plains, New York, United States | |
| United States, North Carolina | |
| Butner, North Carolina, United States | |
| United States, Ohio | |
| Beachwood, Ohio, United States | |
| Chagrin Falls, Ohio, United States | |
| Cincinnati, Ohio, United States | |
| Columbus, Ohio, United States | |
| United States, Oklahoma | |
| Oklahoma City, Oklahoma, United States | |
| United States, Pennsylvania | |
| Media, Pennsylvania, United States | |
| Pittsburgh, Pennsylvania, United States | |
| United States, Tennessee | |
| Memphis, Tennessee, United States | |
| Nashville, Tennessee, United States | |
| United States, Texas | |
| Austin, Texas, United States | |
| Houston, Texas, United States | |
| Terrell, Texas, United States | |
| Waco, Texas, United States | |
| United States, Utah | |
| Salt Lake City, Utah, United States | |
| United States, Virginia | |
| Falls Church, Virginia, United States | |
| Richmond, Virginia, United States | |
| Virginia Beach, Virginia, United States | |
| United States, Washington | |
| Kirkland, Washington, United States | |
| Tacoma, Washington, United States | |
| Vancouver, Washington, United States | |
| United States, Wisconsin | |
| West Allis, Wisconsin, United States | |
Sponsors and Collaborators
AstraZeneca
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00034905 History of Changes |
| Other Study ID Numbers: | 5077US/0043 |
| Study First Received: | May 2, 2002 |
| Last Updated: | January 3, 2013 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Schizophrenia Schizophrenia and Disorders with Psychotic Features Mental Disorders Risperidone Quetiapine Serotonin Antagonists Serotonin Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Pharmacologic Actions |
Physiological Effects of Drugs Antipsychotic Agents Tranquilizing Agents Central Nervous System Depressants Central Nervous System Agents Therapeutic Uses Psychotropic Drugs Dopamine Antagonists Dopamine Agents |
ClinicalTrials.gov processed this record on May 21, 2013